Brainstorm Cell Therapeutics Inc. announced it entered into a Securities Purchase Agreement on February 9, 2026, to sell $1,000,000 of common stock and pre-funded warrants at a price of $0.60 per share. The transaction involves two closings, with the second scheduled 30 days after the first.